MaxCyte, Inc. (MXCT) has a market capitalization of $90.32M and trades at $0.85. The 52-week range is 0.643-2.955.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2, Earnings Per Share (EPS) of $-0.42, annual revenue of $33.03M.
The stock has a beta of 1.45, operates in the Healthcare sector.